A share price of Incyte Corp [INCY] is currently trading at $93.08, up 1.97%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The INCY shares have gain 8.02% over the last week, with a monthly amount glided 12.55%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Incyte Corp [NASDAQ: INCY] stock has seen the most recent analyst activity on October 08, 2025, when Oppenheimer downgraded its rating to a Perform. Previously, Wells Fargo upgraded its rating to Overweight on August 06, 2025, and kept the price target unchanged to $89. On August 01, 2025, Barclays initiated with a Overweight rating and assigned a price target of $90 on the stock. Stifel upgraded its rating to a Buy but stick to its price target of $107 on June 16, 2025. William Blair downgraded its rating to a Mkt Perform. Guggenheim downgraded its rating to Neutral for this stock on March 18, 2025. In a note dated December 17, 2024, UBS initiated an Neutral rating and provided a target price of $77 on this stock.
Incyte Corp experienced fluctuations in its stock price throughout the past year between $53.56 and $92.86. Currently, Wall Street analysts expect the stock to reach $67.5 within the next 12 months. Incyte Corp [NASDAQ: INCY] shares were valued at $93.08 at the most recent close of the market. An investor can expect a potential drop of -27.48% based on the average INCY price forecast.
Analyzing the INCY fundamentals
Trailing Twelve Months sales for Incyte Corp [NASDAQ:INCY] were 4.58B which represents 16.46% growth. Gross Profit Margin for this corporation currently stands at 0.93% with Operating Profit Margin at 0.26%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.24 and Total Capital is 0.26. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 91.46 points at the first support level, and at 89.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 93.94, and for the 2nd resistance point, it is at 94.79.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Incyte Corp [NASDAQ:INCY] is 2.85. In addition, the Quick Ratio stands at 2.78 and the Cash Ratio stands at 1.53. Considering the valuation of this stock, the price to sales ratio is 3.96, the price to book ratio is 4.33 and price to earnings (TTM) ratio is 21.16.
Transactions by insiders
Recent insider trading involved BARRY FLANNELLY, Officer, that happened on Oct 27 ’25 when 33452.0 shares were purchased. EVP & General Counsel, Denton Sheila A. completed a deal on Oct 15 ’25 to sell 277.0 shares. Meanwhile, Officer BARRY FLANNELLY bought 18495.0 shares on Oct 16 ’25.
